During the past decade, Grand River Regional Cancer Centre conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 23 clinical trials were completed, i.e. on average, 127.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grand River Regional Cancer Centre" #1 sponsor was "NCIC Clinical Trials Group" with 10 trials, followed by "Ontario Clinical Oncology Group (OCOG)" with 10 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Canadian Cancer Trials Group" with 7 trials sponsored and "Alliance for Clinical Trials in Oncology" with 7 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grand River Regional Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Grand River Regional Cancer Centre" are "Breast Cancer" (11 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (3 trials), "Invasive Breast Carcinoma" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Grand River Regional Cancer Centre" in a lesser frequency.

Most popular intervention types in "Grand River Regional Cancer Centre" are "Drug" (36 trials), "Other" (16 trials), "Radiation" (14 trials), "Biological" (11 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Quality-of-Life Assessment" (6 trials), "Laboratory Biomarker Analysis" (5 trials), "cetuximab" (4 trials) and "paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Grand River Regional Cancer Centre" are 38 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Grand River Regional Cancer Centre". undefined are not yet recruiting, 8 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Grand River Regional Cancer Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Grand River Regional Cancer Centre, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".